[artículo]
| Título : |
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study |
| Tipo de documento: |
texto impreso |
| Autores: |
Michael S. Ritsner, Autor ; Chanoch Miodownik, Autor ; Yael Ratner, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 34-42 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Trastornos cognitivos, Terapia farmacológica, Glutamatos, Pruebas neuropsicológicas, Trastornos psicóticos, Esquizofrenia. |
| Resumen: |
L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is a first study designed to evaluate the efficacy and tolerability of L-theanine augmentation of antipsychotic treatment of patients with chronic schizophrenia and schizoaffective disorder. |
| Link: |
./index.php?lvl=notice_display&id=27924 |
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 34-42
|
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No.1 (Enero)
